Microcapspeculators.com is an informational website that is highly interested in exploring development stage companies, enroute to finding companies with the best potential
HENDERSON, NV / ACCESSWIRE / July 24, 2018 / BioRestorative Therapies, Inc. (BRTX) is a small stem cell company, that has came across our radar screen. Just a few years ago BRTX was trading as high as $10 plus per share, and a high of $3.75 this year alone. Over the last few weeks interest in BRTX has been climbing, and the company has done higher volume days recently than ever before in BRTX trading history. We are putting this company on full breakout alert, and think everyone should immediately start researching the company.
BioRestorative Therapies, Inc. (BRTX)
Market cap: $11.3 million; current share price: $1.70
BioRestorative Therapies, Inc., a life sciences company focused on stem cell-based therapies, recently reported the findings from Defined Health, which was engaged by the Company to conduct an independent review of BRTX-100, the Company's lead cell therapy candidate designed to treat chronic Lumbar Disc Disease (cLDD). Defined Health is a well-recognized business development and strategy consulting firm that has worked with many of the leading companies in the pharmaceutical, biotech and healthcare industries for over 25 years.
The Company plans to include the results of the review as it further refines its BRTX-100 program (that has been approved by the FDA to commence a Phase 2 clinical trial) by actively engaging in discussions with potential licensing partners, co-development and commercialization activities.
Since announcing this news, the Company has seen increased interest from investors this summer that could potentially lead to a major move in the near future.
Another oversold company in our opinion is AKRX.
Akorn, Inc. (NASDAQ: AKRX)
Market Cap: 2.163B, current share price: $17.34
Akorn, Inc. is a niche pharmaceutical company that develops manufactures, and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. ACR Communication, LLC, which owns Microcapspeculators.com, is not registered with Finra or any other financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. ACR Communication, LLC [and/or] Microcapspeculators.com does not have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. ACR Communication LLC, which owns Microcapspeculators.com, is compensated for its services in the form of cash-based compensation or in equity in the companies it writes about, or a combination of the two. ACR Communication, LLC has been compensated one thousand dollars cash for this article and five thousand dollars total by Regal Consulting. LLC, for news commentary articles for BRTX. BRTX and Regal Consulting, LLC were given an opportunity to edit information included in this article. This article is based solely on public information and the opinions of ACR Communication, LLC, which believes the news commentary to include accurate and complete information. ACR Communication, LLC, will not buy or sell any shares in stocks contained within this article for forty eight hours after this article's distribution.
For Full Legal Disclaimer Click Here.
Contact Information:
Company Name: Microcap Speculators
Contact Person: Media Manager
Email: info@microcapspecualtors.com
Phone: 1-702-720-6310
Country: United States
Website: http://microcapspeculators.com/
SOURCE: ACR Communication, LLC
